Keywords: additional, appros, nippon, kayaku, anti-tumor, agents, japanese

Additional appros for Nippon Kayaku's anti-tumor agents

Article | 28 February 2005

Japanese drumaker Nippon Kayaku has received approval in Japan for additional indications for its anti-tumor agents Randa (5-fluoracil), Lastet (etoposide) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Etoposide

VePesid

Go to drug listing